Vise Technologies Inc. Acquires New Holdings in Integer Holdings Corporation $ITGR

Vise Technologies Inc. purchased a new position in Integer Holdings Corporation (NYSE:ITGR) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,421 shares of the medical equipment provider’s stock, valued at approximately $667,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Teacher Retirement System of Texas acquired a new position in Integer in the first quarter worth approximately $579,000. Xponance Inc. grew its holdings in shares of Integer by 5.1% during the 1st quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider’s stock valued at $297,000 after acquiring an additional 122 shares in the last quarter. Cooke & Bieler LP increased its position in Integer by 6.3% in the 1st quarter. Cooke & Bieler LP now owns 317,393 shares of the medical equipment provider’s stock worth $37,456,000 after purchasing an additional 18,790 shares during the last quarter. Guidance Capital Inc. increased its holdings in Integer by 5.8% in the first quarter. Guidance Capital Inc. now owns 3,819 shares of the medical equipment provider’s stock worth $480,000 after buying an additional 208 shares during the last quarter. Finally, Neo Ivy Capital Management bought a new position in shares of Integer during the 1st quarter valued at $1,527,000. Institutional investors own 99.29% of the company’s stock.

Analysts Set New Price Targets

ITGR has been the subject of a number of research analyst reports. Benchmark reissued a “hold” rating on shares of Integer in a research report on Friday, October 24th. Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $80.00 target price (down from $132.00) on shares of Integer in a research report on Friday, October 24th. Truist Financial lowered their price objective on Integer from $121.00 to $88.00 and set a “buy” rating on the stock in a research note on Friday, October 24th. KeyCorp cut their price target on shares of Integer from $145.00 to $133.00 and set an “overweight” rating for the company in a report on Tuesday, October 21st. Finally, Piper Sandler decreased their target price on Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a report on Friday, October 24th. Four investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Integer currently has a consensus rating of “Hold” and a consensus target price of $96.75.

Integer Stock Down 2.2%

NYSE:ITGR opened at $67.95 on Friday. The stock has a 50-day simple moving average of $92.45 and a 200 day simple moving average of $107.61. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71. The company has a market cap of $2.38 billion, a PE ratio of 28.43, a PEG ratio of 0.60 and a beta of 0.95. Integer Holdings Corporation has a 52-week low of $62.00 and a 52-week high of $146.36.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share for the quarter, beating analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.During the same period in the prior year, the business earned $1.43 earnings per share. The business’s quarterly revenue was up 8.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. On average, sell-side analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Integer announced that its board has authorized a stock buyback plan on Tuesday, November 4th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to reacquire up to 8.3% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s leadership believes its stock is undervalued.

Insider Activity at Integer

In other news, Director Cheryl C. Capps bought 1,600 shares of the firm’s stock in a transaction dated Thursday, November 6th. The shares were bought at an average price of $66.70 per share, with a total value of $106,720.00. Following the completion of the transaction, the director owned 11,702 shares of the company’s stock, valued at $780,523.40. This trade represents a 15.84% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Diron Smith purchased 1,116 shares of the stock in a transaction that occurred on Friday, November 7th. The shares were acquired at an average cost of $67.19 per share, for a total transaction of $74,984.04. Following the completion of the transaction, the executive vice president owned 7,698 shares of the company’s stock, valued at $517,228.62. This trade represents a 16.96% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders have bought 5,843 shares of company stock valued at $384,771. 2.16% of the stock is currently owned by insiders.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.